BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the ... - Marketscreener.com
| BVAXF Stock | USD 0.05 0.01 11.78% |
Roughly 57% of all Biovaxys Technology's stockholders are looking to take a long position. The analysis of current outlook of investing in Biovaxys Technology Corp suggests that some traders are interested regarding Biovaxys Technology's prospects. The current market sentiment, together with Biovaxys Technology's historical and current headlines, can help investors time the market. In addition, many technical investors use Biovaxys Technology Corp stock news signals to limit their universe of possible portfolio assets.
Biovaxys Technology otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Biovaxys daily returns and investor perception about the current price of Biovaxys Technology Corp as well as its diversification or hedging effects on your existing portfolios.
Biovaxys |
BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the ... Marketscreener.com
Read at news.google.com
 |
Biovaxys Technology Fundamental Analysis
We analyze Biovaxys Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biovaxys Technology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biovaxys Technology based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Biovaxys Technology is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Biovaxys Technology Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biovaxys Technology otc stock to make a market-neutral strategy. Peer analysis of Biovaxys Technology could also be used in its relative valuation, which is a method of valuing Biovaxys Technology by comparing valuation metrics with similar companies.
Peers
Biovaxys Technology Related Equities
| VSTM | Verastem | 16.85 | ||||
| ELEV | Elevation Oncology | 3.23 | ||||
| IMMP | Immutep | 2.01 | ||||
| RIGL | Rigel Pharmaceuticals | 0.97 | ||||
| GERN | Geron | 1.20 |
Complementary Tools for Biovaxys OTC Stock analysis
When running Biovaxys Technology's price analysis, check to measure Biovaxys Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovaxys Technology is operating at the current time. Most of Biovaxys Technology's value examination focuses on studying past and present price action to predict the probability of Biovaxys Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovaxys Technology's price. Additionally, you may evaluate how the addition of Biovaxys Technology to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |